tiprankstipranks

Depot - New Portfolio

LR Investment

Depot
Individual Investor
Ranked #595,450 out of 732,075 TipRanks' Investors
Success Rate
19%
7 out of 37
profitable transactions
Average Return
-41.45%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 9.67%
6-Month Return▲ 93.83%
12-Month Return▲ 70.78%
YTD Return▲ 53.79%
Total Return▼ 35.19%

Best Trade

Opened at
Closed at-
Gain▲ 271.45%

Bio

LR Investment Portfolio

Performance

28.12%0-28.12%
▼ 6.45%
▼ 2.17%
▼ 16.73%
Oct 2023
▲ 9.22%
▲ 9.13%
▲ 3.30%
Nov 2023
▲ 5.14%
▲ 4.57%
▲ 28.12%
Dec 2023
▼ 1.87%
▲ 1.59%
▲ 5.52%
Jan 2024
▲ 14.08%
▲ 5.22%
▲ 25.57%
Feb 2024
▲ 5.05%
▲ 3.27%
▲ 0.12%
Mar 2024
▼ 12.40%
▼ 4.03%
▲ 11.04%
Apr 2024
▲ 7.64%
▲ 1.85%
▲ 4.40%
May 2024
TipRanks AverageS&P 500Investor Portfolio
▼ 6.45%▼ 2.17%▼ 16.73%
▲ 9.22%▲ 9.13%▲ 3.30%
▲ 5.14%▲ 4.57%▲ 28.12%
▼ 1.87%▲ 1.59%▲ 5.52%
▲ 14.08%▲ 5.22%▲ 25.57%
▲ 5.05%▲ 3.27%▲ 0.12%
▼ 12.40%▼ 4.03%▲ 11.04%
▲ 7.64%▲ 1.85%▲ 4.40%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
zezjj2eneyo
zezjj2eneyo
zezjj2eneyo
zezjj2eneyo
zezjj2eneyo
zezjj2eneyo
zezjj2eneyo
7vuk8i8n0ri
7vuk8i8n0ri
7vuk8i8n0ri
7vuk8i8n0ri
7vuk8i8n0ri
7vuk8i8n0ri
7vuk8i8n0ri
hub6zzas
hub6zzas
hub6zzas
hub6zzas
hub6zzas
hub6zzas
hub6zzas
te3jk0
te3jk0
te3jk0
te3jk0
te3jk0
te3jk0
te3jk0
vve912
vve912
vve912
vve912
vve912
vve912
vve912
otsp5jwscw
otsp5jwscw
otsp5jwscw
otsp5jwscw
otsp5jwscw
otsp5jwscw
otsp5jwscw
o5lz9u
o5lz9u
o5lz9u
o5lz9u
o5lz9u
o5lz9u
o5lz9u
202xwbfysav
202xwbfysav
202xwbfysav
202xwbfysav
202xwbfysav
202xwbfysav
202xwbfysav
8d7v7zmpis
8d7v7zmpis
8d7v7zmpis
8d7v7zmpis
8d7v7zmpis
8d7v7zmpis
8d7v7zmpis
3sv9y90ddg3
3sv9y90ddg3
3sv9y90ddg3
3sv9y90ddg3
3sv9y90ddg3
3sv9y90ddg3
3sv9y90ddg3
To view investors' portfolios
Sign Up For Free
Allena Pharmaceuticals
▼ 99.18%
3
Close
Dec 14, 2023
Clovis Oncology
▼ 99.75%
3
Close
Jul 11, 2023
Applied Genetic Technologies
▼ 92.86%
3
Close
Nov 30, 2022
ProSiebenSat.1 Media SE
▼ 42.72%
2
Close
Apr 14, 2022
Oramed Pharm
1.84%
▲ 79.49%
5
Buy
Jan 04, 2022
Tiziana Life Sciences
1.46%
▼ 74.79%
2
Buy
Mar 13, 2021
ObsEva
0.02%
▼ 99.72%
2
Buy
Mar 13, 2021
Kazia Therapeutics
0.21%
▼ 97.36%
2
Buy
Mar 13, 2021
Nio
1.09%
▼ 87.07%
2
Buy
Mar 13, 2021
Galectin Therapeutics
7.86%
▲ 40.05%
2
Buy
Mar 13, 2021
Can-Fite BioPharma
0.66%
▼ 89.46%
2
Buy
Mar 13, 2021
Antibe Therapeutics
0.34%
▼ 94.78%
2
Buy
Mar 13, 2021
Actinium Pharmaceuticals
7.03%
▲ 5.03%
2
Buy
Mar 13, 2021
Telix Pharmaceuticals Ltd.
78.04%
▲ 271.45%
2
Buy
Mar 13, 2021
Phio Pharmaceuticals
0.13%
▼ 97.71%
2
Buy
Mar 13, 2021
Immunic
1.07%
▼ 91.48%
2
Buy
Mar 13, 2021
StageZero Life Sciences Ltd
0.23%
▼ 96.95%
2
Buy
Mar 13, 2021
Sorrento Therapeutics
0.01%
▼ 99.85%
2
Buy
Mar 13, 2021